<DOC>
	<DOC>NCT02069067</DOC>
	<brief_summary>The purpose of this study is to describe how often advanced cancer patients experience breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these treatments are.</brief_summary>
	<brief_title>Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated</brief_title>
	<detailed_description />
	<criteria>Diagnosis of neoplasm in advanced stage Chronic pain controlled for at least one week with opioids 60 mg / day morphine equivalent 16 episodes of BTcP within any of 3 days previous to registration into study Signed Informed Consent Â· More than 6 episodes of BTcP within any of 3 days previous to registration into study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>breakthrough cancer pain</keyword>
	<keyword>pain</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>intractable pain</keyword>
	<keyword>cancer</keyword>
</DOC>